$4.29
▲ +$0.18
(+4.38%)
Vol 3.2M
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$593.0M
ROE
-259.1%
Margin
-1259.2%
D/E
398.50
Beta
3.60
52W
$4–$14
Wall Street Consensus
9 analysts · Apr 20262
Strong Buy
6
Buy
1
Hold
0
Sell
0
Strong Sell
88.9%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 0.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Sep 2025 | $-0.10 | $-0.14 | $-0.04 |
| Jun 2025 | $-0.11 | $-1.03 | $-0.92 |
| Mar 2025 | $-0.10 | $-0.12 | $-0.02 |
| Dec 2024 | $-0.09 | $-0.13 | $-0.04 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | $1.1M | $1.2M | $1.1M | $1.2M | $4.9M |
| Net Income | -$7.3M | -$9.2M | -$8.4M | -$75.1M | -$12.9M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -259.1% | -96.6% | -259.1% | -259.1% | -259.1% | -259.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -6263.9% | -767.9% | -2181.8% | -2181.8% | -1259.2% | -1259.2% |
| Gross Margin | 47.7% | 37.4% | 39.3% | 39.3% | 23.0% | 23.0% |
| D/E Ratio | 398.50 | 87.74 | 398.50 | 398.50 | 398.50 | 398.50 |
| Current Ratio | 14.72 | 7.21 | 14.72 | 14.72 | 14.72 | 14.72 |
Key Ratios
ROA (TTM)
-98.7%
P/S (TTM)
70.73
P/B
6.8
EPS (TTM)
$-1.43
CF/Share
$-0.48
52W High
$14.49
52W Low
$3.65
$3.65
52-Week Range
$14.49
Financial Health
Free Cash Flow
-$12.0M
Net Debt
-$286K
Cash
$113.9M
Total Debt
$113.7M
As of Sep 30, 2025
How does ASPI compare to Chemicals peers?
Peer group: Small-cap Chemicals ($300M+) · 9 companies
ASPI valuation vs Chemicals peers
P/E ratio
—
▼
0%
below
peers
(28.1)
vs Peers
vs Industry
Overvalued
P/S ratio
70.7
▲
2391%
above
peers
(2.8)
vs Peers
vs Industry
Overvalued
P/B ratio
6.8
▲
40%
above
peers
(4.8)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(1.4%)
vs Peers
vs Industry
In line
ASPI profitability vs Chemicals peers
ROE
-259.1%
▼
4574%
below
peers
(5.8%)
vs Peers
vs Industry
Weak
Net margin
-1259.2%
▼
15939%
below
peers
(8.0%)
vs Peers
vs Industry
Weak
Gross margin
23.0%
▼
18%
below
peers
(28.0%)
vs Peers
vs Industry
Weak
ROA
-98.7%
▼
3389%
below
peers
(3.0%)
vs Peers
vs Industry
Weak
ASPI financial health vs Chemicals peers
D/E ratio
398.5
▲
494%
above
peers
(67.1)
vs Peers
vs Industry
High debt
Current ratio
14.7
▲
557%
above
peers
(2.2)
vs Peers
vs Industry
Strong liquidity
Beta
3.6
▲
86%
above
peers
(1.9)
vs Peers
vs Industry
More volatile
ASPI fundamentals radar
ASPI
Peer median
Industry
ASPI profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ASPI vs peers: key metrics
Insider Activity
NeutralBuys
0
Sells
0
AINSCOW ROBERT
Chief Operating Officer · Mar 06
8438 shs
MANN PAUL ELLIOT
Officer · Mar 02
162153 shs
Last 90 days
Top Holders
Top 5: 22.2%Blackrock Inc.
6.13%
$29.7M
Vanguard Group Inc
5.78%
$28.0M
Alyeska Investment Group, L…
4.42%
$21.4M
Rovida Investment Managemen…
3.70%
$17.9M
UBS Group AG
2.17%
$10.5M
As of Dec 31, 2025